ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 47 filers reported holding ARALEZ PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $14,000 | -76.7% | 40,000 | 0.0% | 0.00% | – |
| Q1 2018 | $60,000 | +5.3% | 40,000 | 0.0% | 0.00% | – |
| Q4 2017 | $57,000 | -58.4% | 40,000 | -33.3% | 0.00% | -100.0% |
| Q3 2017 | $137,000 | +69.1% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $81,000 | -36.7% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $128,000 | +45.5% | 60,000 | +200.0% | 0.00% | 0.0% |
| Q4 2016 | $88,000 | -9.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $97,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 2,680,140 | $11,820,000 | 7.87% |
| Tiger Legatus Capital Management, LLC | 1,985,000 | $8,754,000 | 3.24% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $12,507,000 | 2.96% |
| Healthcare Value Capital, LLC | 575,000 | $2,536,000 | 2.72% |
| Broadfin Capital, LLC | 4,791,590 | $21,131,000 | 2.35% |
| FNY Managed Accounts LLC | 73,983 | $326,265,000 | 2.19% |
| Elk Creek Partners, LLC | 2,196,055 | $9,685,000 | 0.65% |
| Bryn Mawr Capital Management, LLC | 107,492 | $474,000 | 0.48% |
| Par Capital Management | 6,400,000 | $28,224,000 | 0.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,644,583 | $7,253,000 | 0.30% |